CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 3, 2022 · earnings

CBIO earnings: a negative outcome, -19.9%

On March 3, 2022, CRESCENT BIOPHARMA, INC. reached its earnings. The result was a negative outcome, and the stock moved -19.9% in the window around the event.

The move

$136.00
1d before
$109.00
Event day
$107.00
1d after
$105.00
5d after

Pre-catalyst setup

+3.4%
30-day run-up
5823%
30-day volatility
1.1×
volume spike